246 related articles for article (PubMed ID: 33733040)
1. Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis.
Gülsen A; Ruëff F; Jappe U
Allergol Select; 2021; 5():128-132. PubMed ID: 33733040
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).
Ruëff F; Bauer A; Becker S; Brehler R; Brockow K; Chaker AM; Darsow U; Fischer J; Fuchs T; Gerstlauer M; Gernert S; Hamelmann E; Hötzenecker W; Klimek L; Lange L; Merk H; Mülleneisen NK; Neustädter I; Pfützner W; Sieber W; Sitter H; Skudlik C; Treudler R; Wedi B; Wöhrl S; Worm M; Jakob T
Allergol Select; 2023; 7():154-190. PubMed ID: 37854067
[TBL] [Abstract][Full Text] [Related]
3. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
[TBL] [Abstract][Full Text] [Related]
4. Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose.
Stretz E; Oppel EM; Räwer HC; Chatelain R; Mastnik S; Przybilla B; Ruëff F
Clin Exp Allergy; 2017 Dec; 47(12):1631-1639. PubMed ID: 28802075
[TBL] [Abstract][Full Text] [Related]
5. Anaphylactic reactions in the build-up phase of rush immunotherapy for bee venom allergy in pediatric patients: a single-center experience.
Glaeser A; Müller C; Bode S
Clin Mol Allergy; 2022 Apr; 20(1):4. PubMed ID: 35488298
[TBL] [Abstract][Full Text] [Related]
6. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
[TBL] [Abstract][Full Text] [Related]
7. Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.
Palgan K; Bartuzi Z; Gotz-Zbikowska M
Int J Immunopathol Pharmacol; 2014; 27(1):109-12. PubMed ID: 24674685
[TBL] [Abstract][Full Text] [Related]
8. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
Haeberli G; Brönnimann M; Hunziker T; Müller U
Clin Exp Allergy; 2003 Sep; 33(9):1216-20. PubMed ID: 12956741
[TBL] [Abstract][Full Text] [Related]
9. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
10. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
11. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
12. Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection.
Jarkvist J; Salehi C; Akin C; Gülen T
Allergy; 2020 Jan; 75(1):169-177. PubMed ID: 31306487
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy and biologicals for the treatment of allergy to Hymenoptera stings.
Ridolo E; Pellicelli I; Kihlgren P; Nizi MC; Pucciarini F; Senna G; Incorvaia C
Expert Opin Biol Ther; 2019 Sep; 19(9):919-925. PubMed ID: 31190572
[No Abstract] [Full Text] [Related]
14. Venom immunotherapy: clinical efficacy, safety and contraindications.
Kosnik M; Korosec P
Expert Rev Clin Immunol; 2015; 11(8):877-84. PubMed ID: 26018865
[TBL] [Abstract][Full Text] [Related]
15. Fatal
Rijavec M; Inkret J; Bidovec-Stojković U; Carli T; Frelih N; Kukec A; Korošec P; Košnik M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003556
[No Abstract] [Full Text] [Related]
16. Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT.
Çetin GP; Yılmaz İ; Türk M; Arslan B; Bahçecioğlu SN
Turk J Med Sci; 2022 Aug; 52(4):1223-1234. PubMed ID: 36326412
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L
J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694
[TBL] [Abstract][Full Text] [Related]
18. Risk factors in Hymenoptera venom allergy.
Ruëff F; Kroth J; Przybilla B
Allergol Select; 2017; 1(1):53-58. PubMed ID: 30402602
[TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of hymenoptera venom allergy and venom immunotherapy.
Bilò MB; Tontini C; Martini M; Corsi A; Agolini S; Antonicelli L
Eur Ann Allergy Clin Immunol; 2019 Nov; 51(6):244-258. PubMed ID: 31594296
[TBL] [Abstract][Full Text] [Related]
20. Safety of 100 µg venom immunotherapy rush protocols in children compared to adults.
Stoevesandt J; Hosp C; Kerstan A; Trautmann A
Allergy Asthma Clin Immunol; 2017; 13():32. PubMed ID: 28706538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
